These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32795502)

  • 1. Enhanced anticoagulant activity of hirudin-i analogue co-expressed with arylsulfotransferase in periplasm of E. coli BL21(DE3).
    Rai K; Chu X; Bao Z; Liang Y; Wang X; Yang J; Xian M; Sun Y; Nian R
    J Biotechnol; 2020 Nov; 323():107-112. PubMed ID: 32795502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of hirudin variant-1 by SUMO fusion technology in E. coli.
    Lu W; Cai X; Gu Z; Huang Y; Xia B; Cao P
    Mol Biotechnol; 2013 Jan; 53(1):41-8. PubMed ID: 22371262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life without blood: Molecular and functional analysis of hirudins and hirudin-like factors of the Asian non-hematophagous leech Whitmania pigra.
    Müller C; Wang Z; Hamann M; Sponholz D; Hildebrandt JP
    J Thromb Haemost; 2022 Aug; 20(8):1808-1817. PubMed ID: 35587545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of recombinant hirudin to the natural form by in vitro tyrosine sulfation. Differential substrate specificities of leech and bovine tyrosylprotein sulfotransferases.
    Niehrs C; Huttner WB; Carvallo D; Degryse E
    J Biol Chem; 1990 Jun; 265(16):9314-8. PubMed ID: 2345174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant expression of selectively sulfated proteins in Escherichia coli.
    Liu CC; Schultz PG
    Nat Biotechnol; 2006 Nov; 24(11):1436-40. PubMed ID: 17072302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition.
    Mo W; Zhang YL; Chen HS; Wang LS; Song HY
    J Thromb Thrombolysis; 2009 Aug; 28(2):230-7. PubMed ID: 18998199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis.
    Harvey RP; Degryse E; Stefani L; Schamber F; Cazenave JP; Courtney M; Tolstoshev P; Lecocq JP
    Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1084-8. PubMed ID: 3513162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
    Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of the anticoagulant hirudin: its biotechnological production and clinical practice.
    Sohn JH; Kang HA; Rao KJ; Kim CH; Choi ES; Chung BH; Rhee SK
    Appl Microbiol Biotechnol; 2001 Dec; 57(5-6):606-13. PubMed ID: 11778867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antithrombotic effect of a novel hirudin derivative after reconstruction of carotid artery in rabbits.
    Lu WF; Mo W; Liu Z; Fu WG; Guo DQ; Wang YQ; Song HY
    Thromb Res; 2010 Oct; 126(4):e339-43. PubMed ID: 20483158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirudin variants production by genetic engineered microbial factory.
    Zhang J; Lan N
    Biotechnol Genet Eng Rev; 2018 Oct; 34(2):261-280. PubMed ID: 30095033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged in vivo anticoagulant activity of a hirudin-albumin fusion protein secreted from Pichia pastoris.
    Sheffield WP; Smith IJ; Syed S; Bhakta V
    Blood Coagul Fibrinolysis; 2001 Sep; 12(6):433-43. PubMed ID: 11555696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamic and pharmacological studies on protein-engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis.
    Sun Y; Wang B; Pei J; Luo Y; Yuan N; Xiao Z; Wu H; Luo C; Wang J; Wei S; Pei Y; Fu S; Wang D
    Br J Pharmacol; 2022 Jul; 179(14):3740-3753. PubMed ID: 35135035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
    Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine-O-sulfation is a widespread affinity enhancer among thrombin interactors.
    Ripoll-Rozada J; Maxwell JWC; Payne RJ; Barbosa Pereira PJ
    Biochem Soc Trans; 2022 Feb; 50(1):387-401. PubMed ID: 34994377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM; Chao B; Joseph ML; Jablonski J; Ramachandran KL
    J Biol Chem; 1989 May; 264(15):8692-8. PubMed ID: 2722794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.
    Huang Y; Zhang Y; Zhao B; Xu Q; Zhou X; Song H; Yu M; Mo W
    BMC Struct Biol; 2014 Dec; 14():26. PubMed ID: 25526801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits.
    Ragosta M; Barry WL; Gimple LW; Gertz SD; McCoy KW; Stouffer GA; McNamara CA; Powers ER; Owens GK; Sarembock IJ
    Circulation; 1996 Mar; 93(6):1194-200. PubMed ID: 8653841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biotechnological production of recombinant analogs of hirudin-1 from Hirudo medicinalis].
    Kostromina MA; Esipov RS; Miroshnikov AI
    Bioorg Khim; 2012; 38(2):166-76. PubMed ID: 22792720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.